Characterisation of in vivo release of gentamicin from polymethyl methacrylate cement using a novel method

International Orthopaedics

Volumn 37, Issue 10, 2013, Pages 2031-2036

  Webb, Jason Crispin ^a   Gbejuade, Herbert ^a   Lovering, Andrew ^a   Spencer, Robert ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; GENTAMICIN; PALACOS; POLY(METHYL METHACRYLATE);

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG URINE LEVEL; ELUTION; FOLLOW UP; HUMAN; IMMUNOASSAY; IN VIVO STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS; TREATMENT DURATION; URINALYSIS;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BONE CEMENTS; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENTAMICINS; HIP PROSTHESIS; HUMANS; INJECTIONS, INTRAMUSCULAR; POLYMETHYL METHACRYLATE; POSTOPERATIVE PERIOD; PROSTHESIS-RELATED INFECTIONS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84885422664     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-013-1914-5     Document Type: Article

References (26)

1. Anagnostakos K, Wilmes P, Schmitt E et al (2009) Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 80:193-197
2. Armstrong M, Spencer RF, Lovering AM et al (2002) Antibiotic elution from bone cement: a study of common cement-antibiotic combinations. Hip Int 12:23-27
3. Beeching NJ, Thomas MG, Roberts S et al (1986) Comparative in-vitro activity of antibiotics incorporated in acrylic bone cement. J Antimicrob Chemother 17:173-184
4. Buchholz HW, Elson RA, Heinert K (1984) Antibiotic-loaded acrylic cement: current concepts. Clin Orthop Relat Res 190:96-108
5. Buchholz HW, Engelbrecht H (1970) Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41:511-515
6. Carlsson AK, Lidgren L, Lindberg L (1977) Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 48:405-410
7. Chohfi M, Langlais F, Fourastier J et al (1998) Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop 22:171-177
8. Choi HR, von Knoch F, Kandil AO et al (2012) Retention treatment after periprosthetic total hip arthroplasty infection. Int Orthop 36:723-729
9. Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 437:7-11
10. Dale H, Hallan G, Hallan G et al (2009) Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 80:639-645
11. Elson RA, Jephcott AE, McGechie DB et al (1977) Bacterial infection and acrylic cement in the rat. J Bone Joint Surg Br 59-B:452-457
12. Ericson C, Lidgren L, Lindberg L (1973) Cloxacillin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg Am 55(4):808-813, 843
13. Fink B, Vogt S, Reinsch M et al (2011) Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 469:3141-3147
14. Gristina AG, Costerton JW (1985) Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 67:264-273
15. Hendriks JG, Neut D, van Horn JR et al (2005) Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. J Bone Joint Surg Br 87:272-276
16. Josefsson G, Kolmert L (1993) Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop Relat Res 292:210-214
17. Kuechle DK, Landon GC, Musher DM et al (1991) Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res 264:302-308
18. Lovering AM, White LO, MacGowan AP et al (1996) The elution and binding characteristics of rifampicin for three commercially available protein-sealed vascular grafts. J Antimicrob Chemother 38:599-604
19. Malchau H, Herberts P (1998) Prognosis of total hip replacement. Revision and re- revision rate in THR. A revision-risk study of 148,359 primary operations. Proceedings of AAOS, 65th Annual Meeting of the American Academy of Orthopaedic Surgeons, 19-23 March 1998, New Orleans
20. Montanaro L, Speziale P, Campoccia D et al (2011) Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol 6:1329-1349
21. Sterling GJ, Crawford S, Potter JH et al (2003) The pharmacokinetics of Simplex-tobramycin bone cement. J Bone Joint Surg Br 85:646-649
22. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138
23. Swedish Hip Arthroplasty Register (2010) Annual report 2010. http://www.shpr.se
24. Wahlig H, Dingeldein E (1980) Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 51:49-56
25. Whelton A (1984) The aminoglycosides. Clin Orthop Relat Res 190:66-74
26. White LO, MacGowan AP, Lovering AM et al (1994) Assay of low trough serum gentamicin concentrations by fluorescence polarization immunoassay. J Antimicrob Chemother 33:1068-1070